Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals ...

Minnesota releases a report on the 340B Drug Pricing Program, highlighting the need for transparency in healthcare economics.

University of Minnesota researchers detail the loopholes and pitfalls of drug companies’ discounted pricing program and what Minnesota entities are doing to enhance transparency. The 340B Drug Pricing ...

As the federal drug discount program known as 340B has seen rapid growth in recent years, Minnesota's Department of Health is looking to shine a light on where that growth is occurring.The first year ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...

A first-of-its-kind state report shows safety-net hospitals and health care providers in Minnesota saw $630 million in extra revenue last year — and probably much more — from an obscure program funded ...

As several pharmaceutical companies challenge their role in the 340B drug pricing program, Bristol Myers Squibb filed a lawsuit Nov. 26 against the HHS agency that oversees the federal program.

An example of this unique approach are the discounts given to hospitals rather than patients under the 340B drug discount program. The program, which requires manufacturer discounts on most drugs ...

Johnson & Johnson took a bold step by filing a lawsuit on Nov. 12 against the Health Resources and Services Administration over the 340B Drug Pricing Program. The move came following a public ...

Sanofi plans to phase in its model for different 340B-eligible providers starting early next year. The rebates would apply to 25 drugs, including Dupixent, an injectable used to treat inflammatory ...

according to a report from the Minnesota Department of Health. Specifically, hospitals received $1.5 billion in discounted medicines under the 340B Drug Discount program, but paid $734 million ...